A New Immunohistochemistry Prognostic Score (IPS) Based on MGMT, NDRG-1 and PHLDA-3 for Recurrence and Survival in Resected Pancreatic Neuroendocrine Tumors (PanNET) Abstract #1420

Introduction: In PanNET tumors contradictory data about the prognostic role of MGMT (O6-methylguanine DNA methyltransferase) has been published. NDRG-1 (N-myc downstream-regulated gen-1) and PHLDA-3 (Pleckstrin homology-like domain family A member 3) immunohistochemistry (IHC) expressions have been evaluated in several solid malignant tumors, but their roles in PanNET remain unknown
Aim(s): We aimed to evaluate the prognostic significance of NDRG-1, MGMT and PHLDA-3 by IHC and methylation analysis in resected pancreatic neuroendocrine tumors.
Materials and methods: Ninety-two patients with resected primary PanNET and follow-up > 24 months were included in this study. An immunohistochemistry prognostic score (IPS) was developed based on MGMT, NDRG-1 and PHLDA-3 IHC expression to predict disease free survival (DFS) and overall survival (OS). The discriminatory ability of multivariate models combining the IPS and important clinical variables was assessed with Harrel’s c-index (HCI).
Conference: 13th Annual ENETS conference 2016 (2016)
Category: Basic Science - mTOR and other pathways, signalling, receptors
Presenting Author: Antonio Viudez

To read results and conclusion, please login ...

Further abstracts you may be interested in

No result